These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34985886)

  • 1. Discovery of 3,4-Dihydrobenzo[
    Li Y; Zhang L; Yang R; Qiao Z; Wu M; Huang C; Tian C; Luo X; Yang W; Zhang Y; Li L; Yang S
    J Med Chem; 2022 Feb; 65(3):1786-1807. PubMed ID: 34985886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of benzo[d]oxazol-2(3H)-one derivatives as a new class of TNIK inhibitors for the treatment of colorectal cancer.
    Luo X; Yang R; Li Y; Zhang L; Yang S; Li L
    Bioorg Med Chem Lett; 2022 Jul; 67():128745. PubMed ID: 35447345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNIK inhibition abrogates colorectal cancer stemness.
    Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
    Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer.
    Teng Y; Wu R; Bo W; Tang M; Wang T; Cui X; Li Y; Zhang C; Ma Z; Fu Z; Xu Q; Liu J; Chen L
    Eur J Med Chem; 2024 Mar; 268():116240. PubMed ID: 38422698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors.
    Ho KK; Parnell KM; Yuan Y; Xu Y; Kultgen SG; Hamblin S; Hendrickson TF; Luo B; Foulks JM; McCullar MV; Kanner SB
    Bioorg Med Chem Lett; 2013 Jan; 23(2):569-73. PubMed ID: 23232060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
    Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells.
    Kim J; Moon SH; Kim BT; Chae CH; Lee JY; Kim SH
    PLoS One; 2014; 9(10):e110180. PubMed ID: 25337707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT).
    Sun Y; Gao X; Wu P; Wink M; Li J; Dian L; Liang Z
    Phytomedicine; 2019 Oct; 63():153015. PubMed ID: 31302315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucoma.
    Sun Y; Li Y; Miao Z; Yang R; Zhang Y; Wu M; Lin G; Li L
    Bioorg Med Chem Lett; 2021 Aug; 45():128138. PubMed ID: 34044123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and biological evaluation of fused tetrahydroisoquinoline derivatives as Wnt/β-catenin signaling inhibitors to suppress colorectal cancer.
    Zhou J; Xu B; Shen Q; Zhang Z; Hu Y; Wang M; Su Y; Lei Z; Zhang W; Liu T; Liu H; Hu T; Zhou Y
    Eur J Med Chem; 2024 Oct; 276():116664. PubMed ID: 39018921
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yang T; Hu M; Chen Y; Xiang M; Tang M; Qi W; Shi M; He J; Yuan X; Zhang C; Liu K; Li J; Yang Z; Chen L
    J Med Chem; 2020 Dec; 63(23):14921-14936. PubMed ID: 33256400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of TNIK inhibitors in cancer therapeutics.
    Yamada T; Masuda M
    Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
    Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
    Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-
    Kurasawa O; Miyazaki T; Homma M; Oguro Y; Imada T; Uchiyama N; Iwai K; Yamamoto Y; Ohori M; Hara H; Sugimoto H; Iwata K; Skene R; Hoffman I; Ohashi A; Nomura T; Cho N
    J Med Chem; 2020 Feb; 63(3):1084-1104. PubMed ID: 31895562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 3, 4-disubstituted pyridine derivatives as novel CDK8 inhibitors.
    Zhang H; Jing L; Liu M; Goto M; Lai F; Liu X; Sheng L; Yang Y; Yang Y; Li Y; Chen X; Lee KH; Xiao Z
    Eur J Med Chem; 2021 Nov; 223():113634. PubMed ID: 34147745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insight into TNIK Inhibition.
    Kukimoto-Niino M; Shirouzu M; Yamada T
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF2 and NCK-Interacting Kinase Inhibitors for Colorectal Cancer: In Vitro and Theoretical Validations.
    Arokiaraj SR; Tajuddin NB; Muthusamy K; Jayaraj JM; Alagumuthu M
    ACS Comb Sci; 2020 Nov; 22(11):608-616. PubMed ID: 32960032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326).
    Heffron TP; Heald RA; Ndubaku C; Wei B; Augistin M; Do S; Edgar K; Eigenbrot C; Friedman L; Gancia E; Jackson PS; Jones G; Kolesnikov A; Lee LB; Lesnick JD; Lewis C; McLean N; Mörtl M; Nonomiya J; Pang J; Price S; Prior WW; Salphati L; Sideris S; Staben ST; Steinbacher S; Tsui V; Wallin J; Sampath D; Olivero AG
    J Med Chem; 2016 Feb; 59(3):985-1002. PubMed ID: 26741947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
    Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
    Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity.
    Abdelaziz AM; Diab S; Islam S; Basnet SKC; Noll B; Li P; Mekonnen LB; Lu J; Albrecht H; Milne RW; Gerber C; Yu M; Wang S
    Med Chem; 2019; 15(6):602-623. PubMed ID: 30569866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.